您的购物车当前为空
GNE-616 is a highly potent, metabolically stable, orally bioavailable, and subtype-selective Nav1.7 inhibitor (Ki: 0.79 nM, Kd: 0.38 nM for hNav1.7) for the treatment of chronic pain.

GNE-616 is a highly potent, metabolically stable, orally bioavailable, and subtype-selective Nav1.7 inhibitor (Ki: 0.79 nM, Kd: 0.38 nM for hNav1.7) for the treatment of chronic pain.
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 25 mg | ¥ 19,400 | 3-6月 | |
| 50 mg | ¥ 25,800 | 3-6月 | |
| 100 mg | ¥ 33,500 | 3-6月 |
GNE-616 相关产品
| 产品描述 | GNE-616 is a highly potent, metabolically stable, orally bioavailable, and subtype-selective Nav1.7 inhibitor (Ki: 0.79 nM, Kd: 0.38 nM for hNav1.7) for the treatment of chronic pain. |
| 靶点活性 | Nav1.7 (human): kd:0.38 nM , Nav1.7 (human):ki:0.79 nM , Nav1.6 (human):29 nM (ki), Nav1.2 (human):12 nM (ki) |
| 体外活性 | Site-directed mutagenesis is critical for the isoform selectivity profile of GNE-616. |
| 体内活性 | GNE-616 shows robust activity in a Nav1.7-dependent inherited erythromelalgia (IEM) PK/PD model. |
| 分子量 | 537.53 |
| 分子式 | C24H23F4N5O3S |
| CAS No. | 2349371-81-7 |
| 密度 | no data available |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容